157 related articles for article (PubMed ID: 3520068)
1. Identical-twin (syngeneic) marrow transplantation for hematologic cancers.
Fefer A; Cheever MA; Greenberg PD
J Natl Cancer Inst; 1986 Jun; 76(6):1269-73. PubMed ID: 3520068
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins.
Fefer A; Cheever MA; Greenberg PD; Appelbaum FR; Boyd CN; Buckner CD; Kaplan HG; Ramberg R; Sanders JE; Storb R; Thomas ED
N Engl J Med; 1982 Jan; 306(2):63-8. PubMed ID: 7031474
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.
Fefer A; Cheever MA; Thomas ED; Boyd C; Ramberg R; Glucksberg H; Buckner CD; Storb R
N Engl J Med; 1979 Feb; 300(7):333-7. PubMed ID: 366408
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
6. [Allogenic bone marrow grafts in chronic myeloid leukemia].
Devergie A; Gluckman E; Varrin F; Huret JL; Meletis J; De Castro H; Bombail D; Vilmer E; Traineau R; Boiron M
Nouv Rev Fr Hematol (1978); 1987; 29(1):69-72. PubMed ID: 3295774
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation for chronic granulocytic leukemia.
Lehn P; Devergie A; Benbunan M; Lemercier N; Raffoux C; Rabian C; Vilmer E; Azogui O; Irti T; Gluckman E
J Natl Cancer Inst; 1986 Jun; 76(6):1301-5. PubMed ID: 3520072
[TBL] [Abstract][Full Text] [Related]
8. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.
Fefer A; Sullivan KM; Weiden P; Buckner CD; Schoch G; Storb R; Thomas ED
Prog Clin Biol Res; 1987; 244():401-8. PubMed ID: 3310002
[TBL] [Abstract][Full Text] [Related]
9. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow transplantation as potential therapeutic strategy to cancers].
Hattori K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):953-63. PubMed ID: 6764114
[TBL] [Abstract][Full Text] [Related]
11. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
13. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation for chronic granulocytic leukemia.
Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Pittaluga PA; Repetto M; Piaggio G; Sessarego M; Caimo A; Congiu A
Cancer; 1986 Nov; 58(10):2307-11. PubMed ID: 3530428
[TBL] [Abstract][Full Text] [Related]
15. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow transplantation after intensive chemotherapy].
Masaoka T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
[TBL] [Abstract][Full Text] [Related]
17. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiences.
Santos GW; Saral R; Burns WH; Braine HG; Sensenbrenner LL; Wingard JR; Yeager AM; Jones R; Ambinder RF; Rowley SD
Acta Haematol; 1987; 78 Suppl 1():175-80. PubMed ID: 3124443
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
